SCHEMBL12341956

SCHEMBL12341956

[C-]#[N+]c1cc(F)cc(C#C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12798241 0.79 GRM5 (0.35) —
SCHEMBL314317 0.77 CA12 (0.38) —
SCHEMBL15799295 0.77 CYP1A1 (0.37) —
Bromide SCHEMBL28863753 0.74 CA12 (0.36) —
SCHEMBL12341955 0.72 GRM5 (0.32) —
SCHEMBL15094220 0.67 RAPGEF4 (0.32) —
SCHEMBL10243144 0.67 ACHE (0.36) —
SCHEMBL2813175 0.67 CA12 (0.55) —
SCHEMBL16957149 0.67 CYP1A1 (0.31) —
SCHEMBL2767750 0.67 GRM5 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8268855-B2 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same BRISTOL-MYERS SQUIBB COMPANY (US) 2012-09-18 — — US disclosed
US-20100210629-A1 1,6-DIHYDRO-1,3,5,6-TETRAAZA-AS-INDACENE BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME BRISTOL-MYERS SQUIBB COMPANY 2010-08-19 — — US disclosed
US-7737279-B2 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same BRISTOL-MYERS SQUIBB COMPANY (US) 2010-06-15 — — US disclosed
Send feedback